EUREKAFORB
EUREKA FORBES LIMITED
Each stock's 10,000-path forecast, rendered as light.
EUREKA FORBES LIMITED (EUREKAFORB) Stock Analysis & Case Study
Is EUREKAFORB a good buy? The data-driven verdict.
EUREKA FORBES LIMITED (EUREKAFORB) trades at ₹475,on the numbers it high-risk on the numbers, a Downstox Snapshot Score of 19/100.
On the numbers, EUREKA FORBES LIMITED (EUREKAFORB) high-risk on the numbers, a Downstox Snapshot Score of 19/100, weighing expensive at 47.7× earnings, ROE of 4.3%, a 39% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
EUREKAFORB fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
Is EUREKAFORB overvalued? EUREKAFORB P/E vs its sector
EUREKAFORB's P/E of 47.7× sits above the sector peer median of 15.9×, so on earnings it screens richer than peers.
EUREKAFORB share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 1.7y of EUREKAFORB history (-4%/yr drift, 34%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| EUREKAFORB 2027 | ₹273 | ₹424 | ₹659 | -10% |
| EUREKAFORB 2028 | ₹207 | ₹387 | ₹715 | -17% |
| EUREKAFORB 2029 | ₹163 | ₹351 | ₹736 | -25% |
| EUREKAFORB 2030 | ₹129 | ₹319 | ₹754 | -32% |
| EUREKAFORB 2031 | ₹107 | ₹287 | ₹765 | -39% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability EUREKAFORB goes up, or doubles?
The bull case for EUREKAFORB
- EUREKA FORBES LIMITED is part of the nifty500 universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹736.
The bear case & risks
- A rich 47.7× P/E leaves a thin margin of safety if growth slows.
- Return on equity is a soft 4.3%, capital efficiency trails higher-quality peers.
- A low Piotroski F-Score of 3/9 flags weaker financial health this cycle, worth understanding why before committing.
- The probability model is cautious 12 months out, only a 39% chance of finishing above today's price.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹163.
EUREKAFORB volatility & expected range, how bumpy is the ride?
Over the last 1.7 years EUREKAFORB compounded at -4%/year with annualized volatility of 34%. That volatility implies a 1-year 80% range of ₹273–₹659, the honest backbone behind any single price target.
EUREKAFORB price forecast, the full 60-month probability fan
EUREKAFORB price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds EUREKAFORB hits common targets within the simulated horizon?
Full multi-horizon detail on the EUREKAFORB price target & forecast page.
EUREKAFORB Piotroski F-Score: 3/9, how financially strong is it?
The Piotroski F-Score grades financial strength on nine profitability, leverage and efficiency checks. EUREKAFORB scores 3/9,weak on the financial-strength checks.
EUREKAFORB MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy EUREKAFORB with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.0% | 2.9× |
| ZerodhaCHEAPEST | 31.0% | 3.2× |
| DhanCHEAPEST | 31.0% | 3.2× |
Compare every broker on the EUREKAFORB MTF page.
EUREKAFORB vs peers,sector comparison
About EUREKA FORBES LIMITED: sector, index & market-cap context
EUREKA FORBES LIMITED (EUREKAFORB) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index group, with a market capitalisation of ₹9,175 Cr. See more Nifty 500 stocks.
How the EUREKAFORB Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of EUREKA FORBES LIMITED's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
EUREKAFORB analysis, FAQs
Is EUREKA FORBES LIMITED (EUREKAFORB) a good buy?
On the numbers, EUREKA FORBES LIMITED (EUREKAFORB) high-risk on the numbers, a Downstox Snapshot Score of 19/100, weighing expensive at 47.7× earnings, ROE of 4.3%, a 39% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is EUREKAFORB overvalued or undervalued?
EUREKAFORB trades at 47.7× earnings versus a peer median of 15.9×, so it screens richer than its sector peers.
What is the EUREKAFORB share price target for 2031?
EUREKAFORB's probability-weighted 2031 median target is ₹287, with an 80% range of ₹107–₹765 (10,000-path Monte-Carlo).
What is the probability EUREKAFORB doubles in 5 years?
The modelled probability of EUREKAFORB reaching ₹938 (2×) within 5 years is 6%.
What is the bull case for EUREKAFORB?
EUREKA FORBES LIMITED is part of the nifty500 universe with live, tracked fundamentals on Downstox.
What are the risks in EUREKAFORB?
A rich 47.7× P/E leaves a thin margin of safety if growth slows. Return on equity is a soft 4.3%, capital efficiency trails higher-quality peers. A low Piotroski F-Score of 3/9 flags weaker financial health this cycle, worth understanding why before committing.